Tech Innovations: July 2021
Outsourcing Pharma
JULY 22, 2021
This monthâs roundup of new excipients, manufacturing sites, partnerships, and other items includes news from DFE Pharma, Vetter, and other notable firms.
news-site-partnerships 
Partners come on board GSK’s plan for Stevenage life science hub
pharmaphorum
JULY 4, 2022
GSK’s recently-unveiled plan to develop a bioscience cluster close to its main R&D site in Stevenage, UK, has moved closer to fruition, now that the first partners have joined the initiative. The UBS/Reef joint venture were said to be in a contest with UK property group British Land to secure a partnership deal for the project.
Life Science 
114
114 Join 32,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Medable and Nova Scotia Health Partner to Improve Oncology Trial Access Through Decentralized Clinical Trial Technology
XTalks
FEBRUARY 9, 2023
Leading clinical trials technology platform provider Medable announced a new partnership with Nova Scotia Health Innovation Hub for a two-year pilot study to improve oncology trial access for patients in rural Nova Scotia through Medable’s decentralized clinical trial (DCT) platform.
Pfizer to Acquire Sanford, North Carolina Manufacturing Site from Abzena
Pfizer
JANUARY 17, 2023
Pfizer to Acquire Sanford, North Carolina Manufacturing Site from Abzena. Pfizer to Acquire Sanford, North Carolina Manufacturing Site from Abzena. The site will employ experts in both biological pharmaceutical sciences and biological manufacturing, enabling Pfizer to offer a comprehensive co-development capability. 12.22.2022.
Eli Lilly Announces Nearly $1.5 Billion Investment into New Manufacturing Facilities in North Carolina and Ireland
XTalks
FEBRUARY 3, 2022
million towards a new manufacturing site. In a news release from Lilly, Edgardo Hernandez, senior vice president and president, Lilly Manufacturing Operations, said the investments are geared towards increasing manufacturing capacities to support Lilly’s entry into “an exciting period of growth.”.
AstraZeneca slams brakes on COVID-19 vaccine trial over unexplained participant illness
The Pharma Data
SEPTEMBER 9, 2020
Global trials for AstraZeneca’s much-hyped COVID-19 vaccine, currently in development in partnership with the University of Oxford, have been halted after an unexplained illness was identified in one of the participants. We are committed to the safety of our participants and the highest standards of conduct in our trials.”.
Vaccination 52
52 
Moderna Strikes Manufacturing Deal with Samsung Biologics for COVID-19 Vaccine Production
XTalks
MAY 27, 2021
“We are pleased to partner with Samsung Biologics for this fill and finish manufacturing, which will help us continue to scale up our manufacturing capacity outside of the US,” said Juan Andres, Moderna’s chief technical operations and quality officer in a news release from the company. Moderna COVID-19 Vaccine Manufacturing Woes.
BioNTech, InstaDeep plan joint lab for AI research
pharmaphorum
NOVEMBER 26, 2020
BioNTech may be deeply ensconced in the latter stages of its bid to bring a COVID-19 vaccine to market, but it’s still pushing forward on other fronts, including a partnership with InstaDeep to deploy artificial intelligence and machine learning across its business.
Research 104
104 
Immunotherapy is here to stay
Drug Discovery World
JULY 25, 2023
These include two antibodies for modulating immune responses in cancer and autoimmunity, which are being advanced through pharmaceutical partnerships with Novartis and GlaxoSmithKline. many activated T cells at the tumour site), even though this natural immuno-surveillance was not enough to stop the tumour growth.
Sanofi to build new facility in Canada to increase global availability of high-dose influenza vaccine
The Pharma Data
APRIL 1, 2021
Sanofi announces investment of more than €600 million to build a new vaccine facility in Toronto to increase supply of its differentiated influenza vaccines in Canada, the United States and Europe. Sanofi today announced an investment of more than €600 million in a new vaccine manufacturing facility at its existing site in Toronto, Canada.
Vaccination 52
52 
Keeping tabs on Covid-19: Roche and Regeneron join forces to boost vaccine suppl…
The Pharma Data
AUGUST 21, 2020
However, in this week’s round up, Pharma IQ shares promising news of a Covid-19 candidate collaboration between Roche and Regeneron that looks to boost manufacturing and delivery efforts to patients in need of a cure. Roche and Regeneron join forces to increase global supply of an antibody cocktail for Covid-19.
Vaccination 52
52 
Promising Interim Results from Clinical Trial of NIH-Moderna COVID-19 Vaccine
The Pharma Data
NOVEMBER 16, 2020
The Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) partnership advised on the trial protocol design and endpoints to ensure a harmonized approach across multiple vaccine efficacy trials. Twenty-five NIH-funded COVID-19 Prevention Network(link is external) sites enrolled participants in the trial. El Sahly, M.D.,
Decentralized Trials will dominate Clinical Research space in 2021
Cloudbyz
JANUARY 13, 2021
CRO Partnership Program. The flexibility of the Modular Framework in DCT Model The modular framework in DCT can help patients, sponsors, clinical sites, and other stakeholders in the trial in accessing a wide range of options. Global Site Solutions Summit. Global Site Solutions Summit. Risk Based Monitoring (RBM).
MD Anderson Brings Underdogs into the Fight Against Cancer with Focus Fund
The Pharma Data
OCTOBER 20, 2020
News’ Best Hospitals for Cancer list. In hopes to advance the best and brightest, MD Anderson, in partnership with The Focus Fund GP, has launched the Cancer Focus Fund to propel compelling investigational cancer therapies from preclinical development through Phase II clinical trials. In fact, they’ve been ranked No.
Keeping tabs on Covid-19: Thermo Fisher supports vaccine demand with new manufac…
The Pharma Data
SEPTEMBER 4, 2020
In Pharma IQ ’s first-ever weekly round-up we published news on how Sensyne Health had provided the National Health Service (NHS) in England with a remote monitoring system for the management of diabetes in pregnancy in response to the coronavirus pandemic.
Vaccination 52
52 
Merck to Present at the Barclays Global Healthcare Conference
The Pharma Data
MARCH 3, 2021
We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships. This news release of Merck & Co., For more information, visit www.merck.com and connect with us on Twitter , Facebook , Instagram , YouTube and LinkedIn.
Production 52
52 
Merck to Present at the Cowen 41st Annual Health Care Conference
The Pharma Data
FEBRUARY 25, 2021
We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships. This news release of Merck & Co., For more information, visit www.merck.com and connect with us on Twitter , Facebook , Instagram , YouTube and LinkedIn.
Production 52
52 
Commencement of AAIC; GSK’s Shingles Vaccine Expanded Approval; Pfizer/ BioNtech Agreement with Biovac; Another Failure in Ulcerative Colitis Trial
Delveinsight
JULY 27, 2021
To deal with this challenge, a collaborative partnership between Pfizer, BioNTech and a South African local vaccine producer Biovac entered the scenario. As suggested by analysts, the most rapid, cost-effective and easiest way of vaccine development is regional partnership with prominent vaccines developers.
Vaccination 96
96 
FDA Lifts Clinical Hold on Investigational Lenacapavir for the Treatment and Prevention of HIV
The Pharma Data
MAY 16, 2022
Gilead will now work with study site investigators to fully resume the lenacapavir clinical development programs as quickly as possible. “We Today’s news brings us one step closer to our goal of offering therapeutic options for the diverse communities affected by HIV as we work to end the epidemic for everyone, everywhere.”.
Medicine 52
52 
Space to innovate: where are biotech’s top expansions?
Drug Discovery World
NOVEMBER 8, 2022
While there have been a significant number of new facilities built in the US, there have also been notable expansions for companies in India, the UK and Switzerland, among others.As the sector continues to grow, we share the latest news on which companies are adding new or developing existing office and lab spaces.
Gene Therapy 52
52 
These Words Have (Temporarily) Relocated
Placebo Control
MARCH 18, 2014
Next, I was invited to be a guest blogger for the upcoming Partnerships in Clinical Trials Conference. The good news is that the situation is temporary - Partnerships will actually happen at the end of this month. Suddenly, I've gone from 1 blog to 4. So this blog has been quiet for a bit too long as a result.
Big Data 40
40 
Setting up a virtual clinical trial: Things to consider
Cloudbyz
JANUARY 27, 2021
CRO Partnership Program. More so, the traditional method heavily relies on the in-person collection of data at the hospital sites. For example, shifting study support from in-person visits to virtual visits might not be a big change for site staff but can drastically change the patient experience. Global Site Solutions Summit.
The need for a centralized platform for clinical research study
Cloudbyz
JANUARY 20, 2021
CRO Partnership Program. Moreover, different stakeholders, including clinical trial researchers, sponsors, and hospital sites, all work in silos leading to delay while diminishing the quality of the data. It creates a secure data repository for your sites, patients, CROs, sponsors, and everyone involved. eCOA / ePRO. Contact us.
The evolving role of social media in healthcare
pharmaphorum
DECEMBER 15, 2022
Sharing information and developing partnerships. In this day and age, with fake news and pseudoscience spreading at record speeds, leveraging social media for information-sharing can be tricky to navigate. Facebook and other social media sites offer patients and HCPs easy ways to connect, message each other, and join ‘groups’.
Pharma brands must ‘up the ante’ in their digital presence
pharmaphorum
NOVEMBER 13, 2020
The good news is Pharma businesses have the opportunity to use a multitude of digital marketing channels to advertise on such as LinkedIn, YouTube, Google and Twitter. Rachel Murray is head of partnerships and a strategist for Fountain Partnership. The challenge of compliance. How to maximise your digital marketing strategy.
Branding 108
108 
VALBIOTIS Announces Its Participation in the 39th J.P. Morgan Healthcare Annual Conference as well as in H.C. Wainwright BioConnect from January 11-14, 2021, in Virtual Format
The Pharma Data
JANUARY 10, 2021
LA ROCHELLE, France–( BUSINESS WIRE )– Regulatory News: VALBIOTIS (FR0013254851 – ALVAL / eligible for the PEA/SME) (Paris:ALVAL), a French Research & Development company committed to scientific innovation for preventing and combating metabolic diseases, announces its participation in the prestigious ‘J.P.
Containment 40
40 
Pfizer and Valneva Issue Update on Phase 3 Clinical Trial Evaluating Lyme Disease Vaccine Candidate VLA15
Pfizer
FEBRUARY 16, 2023
These study participants, representing approximately half of the total recruited participants in the trial, are being discontinued following violations of Good Clinical Practice (GCP) at certain clinical trial sites run by a third-party clinical trial site operator.
Yale-NBA Partnership Results in FDA Approval for COVID-19 SalivaDirect Test
XTalks
AUGUST 18, 2020
SalivaDirect, “is simpler, less expensive and less invasive than the traditional method for such testing,” said Yale in a news release this past weekend. Yale-NBA Partnership. They have been a positive element during these challenging times and could serve as models for future interdisciplinary partnerships.
FDA Approval 90
90 
Merck Advances Phase 3 Trial to Evaluate Investigational Islatravir as Once-Monthly Oral PrEP for Women at High Risk for Acquiring HIV-1
The Pharma Data
NOVEMBER 22, 2020
This grant will support ICRC’s work with experienced trial sites in sub-Saharan Africa to enroll, follow and retain the large number of women required for this research. We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships.
Trials 52
52 
Top 10 Medical Device Companies in 2023 by Revenue Statistics and Trends
XTalks
JUNE 12, 2023
The growth is attributed to regulatory approvals, strategic partnerships and the acquisitions of innovative medical technology companies. Medtronic has also embarked on a partnership with GE Healthcare , concentrating on the specific requirements and care demands at Ambulatory Surgery Centers (ASCs) and Office-Based Labs (OBLs).
FDA Approval 98
98 
Pfizer and International Trachoma Initiative Deliver One Billionth Zithromax® Dose Toward Trachoma Elimination by 2030
Pfizer
JANUARY 27, 2023
This milestone marks a significant achievement and was made possible by decades-long partnerships to eliminate trachoma – the leading infectious cause of blindness globally. Together, trachoma elimination efforts around the world have successfully reduced the trachoma burden by 92 percent since 2002, i with an estimated 217.9
Bacteria 75
75 
Pfizer and BioNTech’s COVID-19 Vaccine Shows Positive Early Trial Results
XTalks
NOVEMBER 10, 2020
Despite this, Pfizer’s stocks surged yesterday amid excitement surrounding the news, as people cling on to hope for a pandemic-ending vaccine to be available soon. Local reactions, the most common being injection site pain, and systemic events after injection were dose-dependent, mild to moderate and transient.
Vaccination 75
75 
Edwards RESILIA Tissue Aortic Valve Demonstrates Favorable Safety and Efficacy at Five Years
The Pharma Data
JANUARY 30, 2021
lead enroller and site principal investigator for the COMMENCE study and the Brooke Roberts-William M. The COMMENCE study is a prospective, non-randomized, multicenter, single-arm investigational device exemption (IDE) trial comprised of 689 patients at 27 clinical sites across the United States and Europe. Bavaria, M.D.,
A history of AstraZeneca
pharmaphorum
SEPTEMBER 18, 2020
“Picking the next merger candidate is hard enough, doing so before everyone else jumps on board, then picking the right time to sell makes for a dangerous investment game,” said one BBC News article from December 1998. However, this new name has since caused confusion between Prilosec and Prozac. Zeneca Group plc. Pascal Soriot.
Pharma Companies 115
115 
Lilly to Commit $5 Million to Direct Relief’s Fund for Health Equity | Eli Lilly and Company
The Pharma Data
MAY 3, 2021
who in turn operate more than 5,000 clinical sites and provide care to millions of people. www.lilly.com/news.?I-LLY. Lilly 30×30 initiatives include activities across three areas of impact: pipeline, programs and partnerships. About Eli Lilly and Company? To learn more about Lilly , please visit us at? www.lilly.com ?and?
Medicine 40
40 
2020 in review: COVID-19 and patient centric clinical trials
pharmaphorum
DECEMBER 22, 2020
The RECOVERY Trial, a multi-arm RCT studying the efficacy of several repurposed treatments in COVID-19, recruited a staggering 2,000-plus people across 16 NHS sites in little more than three weeks. The studies are being covered on the news and that’s great for letting people know how they can get involved in research right now.
Emotional empathy is driving brand equity
pharmaphorum
AUGUST 13, 2020
T-Mobile went into partnership with Verizon, AT&T, and iHeartMedia to give 40,000 phone chargers to hospitals, putting frightened, isolated patients back in touch with loved ones. Nickelodeon launched a free site to keep kids out of their parents’ hair. Brands are contributing in myriad different, relevant and engaging ways.
Branding 95
95 
How to choose a reliable CTMS
Cloudbyz
DECEMBER 30, 2020
CRO Partnership Program. Know where the CTMS would be hosted – is it be in the site location or at the vendor’s place? Global Site Solutions Summit. Global Site Solutions Summit. Risk Based Monitoring (RBM). eCOA / ePRO. Safety & Pharmacovigilance. Patient Support Services. Technology and Service Partners. Contact us.
Pfizer and BioNTech to provide 500 million doses of COVID-19 vaccine to U.S. government for donation to poorest nations
The Pharma Data
JUNE 24, 2021
Our partnership with the U.S. based sites involved in the production of the COVID-19 vaccine include Kalamazoo, MI, Andover, MA, Chesterfield, MO, Groton, CT, and McPherson, KS. government will help bring hundreds of millions of doses of our vaccine to the poorest countries around the world as quickly as possible. facilities.
Vaccination 52
52 
The use of base editing in stem-cell based therapies
Drug Discovery World
JANUARY 23, 2023
A recent US and South Korean pharmaceutical partnership unveiled plans to trial a diabetes treatment using iPSC-derived pancreatic beta cells 16. The Pin-point base editing system utilises a Cas component with an independent deaminase that is recruited to a DNA target site via a guide RNA with a tethered aptameric sequence 25.
Gene Editing 52
52 
Overcoming inefficiencies to improve access to cell and gene therapy
Drug Discovery World
MARCH 13, 2023
Lauren Collison , PhD, Senior VP, Operations & Site Head, KBI Biopharma, reflects. At the end of the day, this is what will best help the patients they’re trying to reach. To set their partnership up for success, developers should approach CDMOs with a clear idea of their desired timeline. August 2020. April 4, 2022.
Gene Therapy 52
52 
Merck to Help Produce Johnson & Johnson’s COVID-19 Vaccine
The Pharma Data
MARCH 2, 2021
Under the terms of the BARDA agreement, Merck will adapt and make available some of the company’s existing manufacturing sites to accelerate manufacturing efforts for SARS-CoV-2/COVID-19 vaccines and medicines. This news release of Merck & Co., Forward-Looking Statement of Merck & Co., Kenilworth, N.J., Kenilworth, N.J.,
Vaccination 40
40 
Continuing to Follow the Science: An Open Letter from Pfizer Chairman and CEO Dr. Albert Bourla
Pfizer
APRIL 14, 2023
That’s reassuring news for millions of people who have already received our vaccine and are slowly returning to a more normal life. It is common, following the administration of many vaccines, to observe short-term reactions such as pain, redness, or swelling at the injection site, as well as a headache or fever.
Vaccination 52
52 
Sensorion and Novasep Announce Signature of a Gene Therapy Product Development and Manufacturing Agreement
The Pharma Data
OCTOBER 26, 2020
Sensorion is currently advancing two preclinical gene therapy programs conducted under a broad multi-program research partnership with the Genetics and Physiology of Hearing Unit at Institut Pasteur (Paris). 27, 2020 06:30 UTC. Mutations in OTOF lead to severe or profound congenital hearing loss.
Gene Therapy 52
52 
Let's personalize your content